Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)

2018614 citationsJournal Article

Authors

Mohammad Shafi Kuchay · Medanta The Medicity

Sonal Krishan · Medanta The Medicity

Sunil Kumar Mishra · Medanta The Medicity

Khalid Farooqui · Medanta The Medicity

Manish Kumar Singh · Medanta The Medicity

Jasjeet Singh Wasir · Medanta The Medicity

Beena Bansal ·

Abstract

When included in the standard treatment for type 2 diabetes, empagliflozin reduces liver fat and improves ALT levels in patients with type 2 diabetes and NAFLD.

Topics & Keywords

Liver Disease Diagnosis and Treatment Diet, Metabolism, and Disease Pancreatic function and diabetes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 41, Issue 8, pp. 1801-1808

DOI: 10.2337/dc18-0165

Field-Weighted Citation Impact: 38.62